Cellivery Acquires Patent Rights Related to Parkinson's Disease Treatment
[Asia Economy Reporter Oh Ju-yeon] Cellivery announced on the 13th that it has obtained a U.S. patent related to a Parkinson's disease treatment. The company stated, "The patent concerns the composition, efficacy, and manufacturing method of the Parkinson's disease treatment candidate substance cell/tissue-permeable parkin (improved cell-permeable Parkin: iCP-Parkin)," adding, "This allows us to negotiate from a favorable position during technology transfer discussions with global pharmaceutical companies."
Hot Picks Today
Even with High Oil Price Relief Payment, Additional 300,000 Won Per Person to Be Provided... Applications Open from the 18th in This Region
- "Invested 95% in Hynix and Reached 10 Billion Won"... Japanese Investor's Proof Post Goes Viral
- "Why Is the Korean Stock Market Surging?"... Even Italy Is Astonished by the KOSPI Rally
- "You Don't Need to Go to the Gym": The Best Exercises for Lowering Hypertension
- "That Thing Wakes Up Every Night" ... Suspicious Object Covers Rural Village
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
